Drug of choice for organophosphorous poisoning: March 2013 (e)
The mainstay treatment for this is atropine, which is an anticholinergic. Atropine works by blocking the action of acetylcholine at muscarinic receptors, thereby counteracting the effects of excess acetylcholine. Another important drug is pralidoxime (2-PAM), which is a cholinesterase reactivator. It helps to reactivate the inhibited acetylcholinesterase enzyme by removing the phosphoryl group from the enzyme.
Now, looking at the options, the correct answer should be atropine. But wait, maybe the options included pralidoxime. Wait, the user didn't provide the actual options, just the correct answer. Hmm, the user mentioned the correct answer is given as "Correct Answer: [Letter]. [Answer Text]". Since the user hasn't provided the options, I need to infer based on standard knowledge.
In most cases, the drug of choice for organophosphorus poisoning is atropine. Pralidoxime is also used, but atropine is the primary. So the correct answer here is likely atropine. The other options might include things like neostigmine (which is a cholinesterase inhibitor, so definitely wrong), or maybe something else like diazepam for seizures, but that's not the primary treatment.
So, the core concept is that organophosphorus poisoning leads to cholinergic crisis, treated with atropine and pralidoxime. The correct answer is atropine. The other options would be incorrect because they either exacerbate the condition or aren't the primary treatment. The clinical pearl is to remember the combination of atropine and pralidoxime, but atropine is the first line.
**Core Concept**
Organophosphorus compounds irreversibly inhibit acetylcholinesterase, causing cholinergic crisis via excessive acetylcholine. Treatment targets both symptomatic relief and enzyme reactivation. Atropine, an anticholinergic, is the cornerstone for counteracting muscarinic receptor overstimulation.
**Why the Correct Answer is Right**
Atropine competitively inhibits acetylcholine binding to muscarinic receptors, alleviating symptoms like bronchospasm, secretions, and bradycardia. It does not reverse nicotinic effects (e.g., muscle fasciculations) or reactivates the enzyme. Pralidoxime (2-PAM) is used alongside atropine to reactivate phosphorylated acetylcholinesterase but is less effective once the enzyme "ages."
**Why Each Wrong Option is Incorrect**
**Option A:** Neostigmine enhances cholinergic effects, worsening poisoning.
**Option B:** Diazepam may control seizures but addresses only secondary complications.
**Option C:** Naloxone reverses opioid toxicity, not organophosphorus effects.
**Clinical Pearl / High-Yield Fact**